{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:37:08Z","timestamp":1789123028267,"version":"build-2803163510"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Henan province development breakthrough program","award":["242102310349"],"award-info":[{"award-number":["242102310349"]}]},{"name":"project of Naval Medical Center of PLA","award":["21TPQN0802"],"award-info":[{"award-number":["21TPQN0802"]}]},{"name":"Shanghai Science and Technology Program","award":["21S21902800"],"award-info":[{"award-number":["21S21902800"]}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["21ZR1427300"],"award-info":[{"award-number":["21ZR1427300"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Frontiers Research Center of the Hadal Biosphere"},{"name":"SciTech Funding by CSPFTZ Lingang Special Area Marine Biomedical Innovation Platform"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-024-01954-7","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T07:11:51Z","timestamp":1733382711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Machine learning-aided discovery of T790M-mutant EGFR inhibitor CDDO-Me effectively suppresses non-small cell lung cancer growth"],"prefix":"10.1186","volume":"22","author":[{"given":"Rui","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiting","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haigang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Hemmings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beier","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"1954_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrclinonc.2014.104","volume":"11","author":"DR Camidge","year":"2014","unstructured":"Camidge DR, Pao W, Sequist LV. Acquired resistance to TKIs in solid tumours: learning from lung cancer. Nat Rev Clin Oncol. 2014;11:473\u201381.","journal-title":"Nat Rev Clin Oncol"},{"key":"1954_CR2","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1634\/theoncologist.2013-0096","volume":"18","author":"JM Weiss","year":"2013","unstructured":"Weiss JM, Stinchcombe TE. Second-line therapy for Advanced NSCLC. Oncologist. 2013;18:947\u201353.","journal-title":"Oncologist"},{"key":"1954_CR3","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/nm.3388","volume":"19","author":"CR Chong","year":"2013","unstructured":"Chong CR, J\u00e4nne PA. The quest to overcome resistance to EGFR-targeted therapies in cancer. Nat Med. 2013;19:1389\u2013400.","journal-title":"Nat Med"},{"key":"1954_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.phrs.2015.10.021","volume":"103","author":"R Roskoski","year":"2016","unstructured":"Roskoski R. Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes. Pharmacol Res. 2016;103:26\u201348.","journal-title":"Pharmacol Res"},{"key":"1954_CR5","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/nrc2947","volume":"10","author":"W Pao","year":"2010","unstructured":"Pao W, Chmielecki J. Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer. 2010;10:760\u201374.","journal-title":"Nat Rev Cancer"},{"key":"1954_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12943-018-0793-1","volume":"17","author":"Q Liu","year":"2018","unstructured":"Liu Q, Yu S, Zhao W, Qin S, Chu Q, Wu K. EGFR-TKIs resistance via EGFR-independent signaling pathways. Mol Cancer. 2018;17:53.","journal-title":"Mol Cancer"},{"key":"1954_CR7","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1073\/pnas.0709662105","volume":"105","author":"C-H Yun","year":"2008","unstructured":"Yun C-H, Mengwasser KE, Toms AV, Woo MS, Greulich H, Wong K-K, et al. The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP. Proc Natl Acad Sci USA. 2008;105:2070\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1954_CR8","doi-asserted-by":"publisher","first-page":"105583","DOI":"10.1016\/j.phrs.2021.105583","volume":"167","author":"R-F Dong","year":"2021","unstructured":"Dong R-F, Zhu M-L, Liu M-M, Xu Y-T, Yuan L-L, Bian J, et al. EGFR mutation mediates resistance to EGFR tyrosine kinase inhibitors in NSCLC: from molecular mechanisms to clinical research. Pharmacol Res. 2021;167:105583.","journal-title":"Pharmacol Res"},{"key":"1954_CR9","doi-asserted-by":"crossref","unstructured":"Westover D. Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors. Ann Oncol. 2018;29.","DOI":"10.1093\/annonc\/mdx703"},{"key":"1954_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.drup.2015.05.002","volume":"20","author":"M Juchum","year":"2015","unstructured":"Juchum M, G\u00fcnther M, Laufer SA. Fighting cancer drug resistance: opportunities and challenges for mutation-specific EGFR inhibitors. Drug Resist Updates. 2015;20:12\u201328.","journal-title":"Drug Resist Updates"},{"key":"1954_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13045-022-01311-6","volume":"15","author":"K Shi","year":"2022","unstructured":"Shi K, Wang G, Pei J, Zhang J, Wang J, Ouyang L, et al. Emerging strategies to overcome resistance to third-generation EGFR inhibitors. J Hematol Oncol. 2022;15:94.","journal-title":"J Hematol Oncol"},{"key":"1954_CR12","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2174\/1568026620666200303123102","volume":"20","author":"DA Sabbah","year":"2020","unstructured":"Sabbah DA, Hajjo R, Sweidan K. Review on epidermal growth factor receptor (EGFR) structure, signaling pathways, interactions, and recent updates of EGFR inhibitors. CTMC. 2020;20:815\u201334.","journal-title":"CTMC"},{"key":"1954_CR13","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.apsb.2015.07.001","volume":"5","author":"L Huang","year":"2015","unstructured":"Huang L, Fu L. Mechanisms of resistance to EGFR tyrosine kinase inhibitors. Acta Pharm Sinica B. 2015;5:390\u2013401.","journal-title":"Acta Pharm Sinica B"},{"key":"1954_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","volume":"18","author":"J Vamathevan","year":"2019","unstructured":"Vamathevan J, Clark D, Czodrowski P, Dunham I, Ferran E, Lee G, et al. Applications of machine learning in drug discovery and development. Nat Rev Drug Discov. 2019;18:463\u201377.","journal-title":"Nat Rev Drug Discov"},{"key":"1954_CR15","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s41589-023-01349-8","volume":"19","author":"G Liu","year":"2023","unstructured":"Liu G, Catacutan DB, Rathod K, Swanson K, Jin W, Mohammed JC, et al. Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii. Nat Chem Biol. 2023;19:1342\u201350.","journal-title":"Nat Chem Biol"},{"key":"1954_CR16","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ccell.2020.09.014","volume":"38","author":"BM Kuenzi","year":"2020","unstructured":"Kuenzi BM, Park J, Fong SH, Sanchez KS, Lee J, Kreisberg JF, et al. Predicting Drug Response and Synergy using a deep learning model of Human Cancer cells. Cancer Cell. 2020;38:672\u2013e6846.","journal-title":"Cancer Cell"},{"key":"1954_CR17","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1038\/s41467-021-22170-8","volume":"12","author":"H Gerdes","year":"2021","unstructured":"Gerdes H, Casado P, Dokal A, Hijazi M, Akhtar N, Osuntola R, et al. Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs. Nat Commun. 2021;12:1850.","journal-title":"Nat Commun"},{"key":"1954_CR18","doi-asserted-by":"crossref","unstructured":"Seyyed-Kalantari L. Underdiagnosis bias of artificial intelligence algorithms applied to chest radiographs in under-served patient populations. Nat Med. 2021;27.","DOI":"10.1038\/s41591-021-01595-0"},{"key":"1954_CR19","doi-asserted-by":"crossref","unstructured":"Zaky AA, Shim J-H, El-Aty AMA, Bioactivities. Applications, Safety, and Health Benefits of Bioactive Peptides from Food and By-Products: a review. Front Nutr. 2022;8.","DOI":"10.3389\/fnut.2021.815640"},{"key":"1954_CR20","doi-asserted-by":"crossref","unstructured":"Ono A. Mutant allele frequency predicts the efficacy of EGFR-TKIs in lung adenocarcinoma harboring the L858R mutation. Ann Oncol. 2014;25.","DOI":"10.1093\/annonc\/mdu251"},{"key":"1954_CR21","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger MM, Carchia M, Irwin JJ, Shoichet BK. Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for Better Benchmarking. J Med Chem. 2012;55:6582\u201394.","journal-title":"J Med Chem"},{"key":"1954_CR22","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1021\/jm049092j","volume":"48","author":"N Triballeau","year":"2005","unstructured":"Triballeau N, Acher F, Brabet I, Pin J-P, Bertrand H-O. Virtual screening Workflow Development guided by the receiver operating characteristic curve Approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. J Med Chem. 2005;48:2534\u201347.","journal-title":"J Med Chem"},{"key":"1954_CR23","doi-asserted-by":"crossref","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3\u201325. 1. Advanced Drug Delivery Reviews. 2001;46:3\u201326.","DOI":"10.1016\/S0169-409X(00)00129-0"},{"key":"1954_CR24","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/nar\/gkab255","volume":"49","author":"G Xiong","year":"2021","unstructured":"Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C, et al. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 2021;49:W5\u201314.","journal-title":"Nucleic Acids Res"},{"key":"1954_CR25","doi-asserted-by":"publisher","first-page":"764699","DOI":"10.3389\/fphar.2021.764699","volume":"12","author":"S Yan","year":"2022","unstructured":"Yan S, Zhang B, Feng J, Wu H, Duan N, Zhu Y, et al. FGFC1 selectively inhibits Erlotinib-Resistant Non-small Cell Lung Cancer via Elevation of ROS mediated by the EGFR\/PI3K\/Akt\/mTOR pathway. Front Pharmacol. 2022;12:764699.","journal-title":"Front Pharmacol"},{"key":"1954_CR26","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30:2785\u201391.","journal-title":"J Comput Chem"},{"key":"1954_CR27","doi-asserted-by":"crossref","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings. J Chem Inf Model. 2021;61:3891\u201398.","DOI":"10.1021\/acs.jcim.1c00203"},{"key":"1954_CR28","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1002\/elps.1150181505","volume":"18","author":"N Guex","year":"1997","unstructured":"Guex N, Peitsch MC. SWISS-MODEL and the Swiss\u2010pdb viewer: an environment for comparative protein modeling. Electrophoresis. 1997;18:2714\u201323.","journal-title":"Electrophoresis"},{"key":"1954_CR29","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA. Development and testing of a general amber force field. J Comput Chem. 2004;25:1157\u201374.","journal-title":"J Comput Chem"},{"key":"1954_CR30","doi-asserted-by":"crossref","unstructured":"Ponder JW, Case DA. Force Fields for Protein Simulations. Advances in Protein Chemistry [Internet]. Elsevier; 2003 [cited 2023 Dec 6]. pp. 27\u201385. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S006532330366002X","DOI":"10.1016\/S0065-3233(03)66002-X"},{"key":"1954_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1248\/cpb.c23-00577","volume":"72","author":"A Nurani","year":"2024","unstructured":"Nurani A, Yamashita Y, Taki Y, Takada Y, Itoh Y, Suzuki T. Identification of a histone deacetylase 8 inhibitor through drug screenings based on machine learning. Chem Pharm Bull. 2024;72:173\u20138.","journal-title":"Chem Pharm Bull"},{"key":"1954_CR32","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1021\/ci100050t","volume":"50","author":"D Rogers","year":"2010","unstructured":"Rogers D, Hahn M. Extended-connectivity fingerprints. J Chem Inf Model. 2010;50:742\u201354.","journal-title":"J Chem Inf Model"},{"key":"1954_CR33","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1080\/0960085X.2021.1927212","volume":"31","author":"N Kordzadeh","year":"2022","unstructured":"Kordzadeh N, Ghasemaghaei M. Algorithmic bias: review, synthesis, and future research directions. Eur J Inform Syst. 2022;31:388\u2013409.","journal-title":"Eur J Inform Syst"},{"key":"1954_CR34","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/nbt1206-1565","volume":"24","author":"WS Noble","year":"2006","unstructured":"Noble WS. What is a support vector machine? Nat Biotechnol. 2006;24:1565\u20137.","journal-title":"Nat Biotechnol"},{"key":"1954_CR35","doi-asserted-by":"crossref","unstructured":"Yang F-J, An Implementation of Naive Bayes Classifier. 2018 International Conference on Computational Science and Computational Intelligence (CSCI) [Internet]. Las Vegas, NV, USA: IEEE; 2018 [cited 2024 May 10]. pp. 301\u20136. https:\/\/ieeexplore.ieee.org\/document\/8947658\/","DOI":"10.1109\/CSCI46756.2018.00065"},{"key":"1954_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/3459665","volume":"54","author":"P Cunningham","year":"2022","unstructured":"Cunningham P, Delany SJ. k-Nearest Neighbour classifiers - A Tutorial. ACM Comput Surv. 2022;54:1\u201325.","journal-title":"ACM Comput Surv"},{"key":"1954_CR37","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C, XGBoost:. A Scalable Tree Boosting System. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining [Internet]. 2016 [cited 2024 May 10]. pp. 785\u201394. http:\/\/arxiv.org\/abs\/1603.02754","DOI":"10.1145\/2939672.2939785"},{"key":"1954_CR38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1142\/S0129065795000299","volume":"06","author":"P Arena","year":"1995","unstructured":"Arena P, Fortuna L, Re R, Xibilia MG. MULTILAYER PERCEPTRONS TO APPROXIMATE COMPLEX VALUED FUNCTIONS. Int J Neur Syst. 1995;06:435\u201346.","journal-title":"Int J Neur Syst"},{"key":"1954_CR39","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrd1032","volume":"2","author":"H Van De Waterbeemd","year":"2003","unstructured":"Van De Waterbeemd H, Gifford E. ADMET IN SILICO MODELLING: TOWARDS PREDICTION PARADISE? Nat Rev Drug Discov. 2003;2:192\u2013204.","journal-title":"Nat Rev Drug Discov"},{"key":"1954_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliver Rev. 1997;23:3\u201325.","journal-title":"Adv Drug Deliver Rev"},{"key":"1954_CR41","doi-asserted-by":"publisher","first-page":"eaaw8412","DOI":"10.1126\/scitranslmed.aaw8412","volume":"11","author":"A Lin","year":"2019","unstructured":"Lin A, Giuliano CJ, Palladino A, John KM, Abramowicz C, Yuan ML, et al. Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials. Sci Transl Med. 2019;11:eaaw8412.","journal-title":"Sci Transl Med"},{"key":"1954_CR42","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng H-Y, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002;45:2615\u201323.","journal-title":"J Med Chem"},{"key":"1954_CR43","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.canlet.2020.05.024","volume":"489","author":"X-H Huang","year":"2020","unstructured":"Huang X-H, Yan X, Zhang Q-H, Hong P, Zhang W-X, Liu Y-P, et al. Direct targeting of HSP90 with daurisoline destabilizes \u03b2-catenin to suppress lung cancer tumorigenesis. Cancer Lett. 2020;489:66\u201378.","journal-title":"Cancer Lett"},{"key":"1954_CR44","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s13046-018-0987-9","volume":"37","author":"W Chen","year":"2018","unstructured":"Chen W, Li P, Liu Y, Yang Y, Ye X, Zhang F, et al. Isoalantolactone induces apoptosis through ROS-mediated ER stress and inhibition of STAT3 in prostate cancer cells. J Exp Clin Canc Res. 2018;37:309.","journal-title":"J Exp Clin Canc Res"},{"key":"1954_CR45","doi-asserted-by":"crossref","unstructured":"Zhou S-F, Wang Y-Y, Yang Y-X, He Z, Zhao R, Hong Z et al. Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells. Drug Des Dev Ther. 2015;993.","DOI":"10.2147\/DDDT.S73493"},{"key":"1954_CR46","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1158\/1078-0432.CCR-12-2246","volume":"19","author":"HA Yu","year":"2013","unstructured":"Yu HA, Arcila ME, Rekhtman N, Sima CS, Zakowski MF, Pao W, et al. Analysis of tumor specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 patients with EGFR -Mutant lung cancers. Clin Cancer Res. 2013;19:2240\u20137.","journal-title":"Clin Cancer Res"},{"key":"1954_CR47","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/nprot.2014.138","volume":"9","author":"R Jafari","year":"2014","unstructured":"Jafari R, Almqvist H, Axelsson H, Ignatushchenko M, Lundb\u00e4ck T, Nordlund P, et al. The cellular thermal shift assay for evaluating drug target interactions in cells. Nat Protoc. 2014;9:2100\u201322.","journal-title":"Nat Protoc"},{"key":"1954_CR48","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2009.04.025","volume":"137","author":"N Jura","year":"2009","unstructured":"Jura N, Endres NF, Engel K, Deindl S, Das R, Lamers MH, et al. Mechanism for activation of the EGF Receptor Catalytic Domain by the Juxtamembrane Segment. Cell. 2009;137:1293\u2013307.","journal-title":"Cell"},{"key":"1954_CR49","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1476-4598-12-46","volume":"12","author":"K Kampa-Schittenhelm","year":"2013","unstructured":"Kampa-Schittenhelm K, Heinrich M, Akmut F, Rasp K, Illing B, D\u00f6hner H, et al. Cell cycle-dependent activity of the novel dual PI3K-MTORC1\/2 inhibitor NVP-BGT226 in acute leukemia. Mol Cancer. 2013;12:46.","journal-title":"Mol Cancer"},{"key":"1954_CR50","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","volume":"141","author":"MA Lemmon","year":"2010","unstructured":"Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2010;141:1117\u201334.","journal-title":"Cell"},{"key":"1954_CR51","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1021\/acsmedchemlett.8b00368","volume":"9","author":"C Jim\u00e9nez","year":"2018","unstructured":"Jim\u00e9nez C. Marine Natural products in Medicinal Chemistry. ACS Med Chem Lett. 2018;9:959\u201361.","journal-title":"ACS Med Chem Lett"},{"key":"1954_CR52","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mib.2019.03.004","volume":"51","author":"MDT Torres","year":"2019","unstructured":"Torres MDT, De La Fuente-Nunez C. Toward computer-made artificial antibiotics. Curr Opin Microbiol. 2019;51:30\u20138.","journal-title":"Curr Opin Microbiol"},{"key":"1954_CR53","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1016\/j.csbj.2021.05.037","volume":"19","author":"A Rajput","year":"2021","unstructured":"Rajput A, Thakur A, Mukhopadhyay A, Kamboj S, Rastogi A, Gautam S, et al. Prediction of repurposed drugs for coronaviruses using artificial intelligence and machine learning. Comput Struct Biotechnol J. 2021;19:3133\u201348.","journal-title":"Comput Struct Biotechnol J"},{"key":"1954_CR54","doi-asserted-by":"publisher","first-page":"bbab271","DOI":"10.1093\/bib\/bbab271","volume":"22","author":"K Fan","year":"2021","unstructured":"Fan K, Cheng L, Li L. Artificial intelligence and machine learning methods in predicting anti-cancer drug combination effects. Brief Bioinform. 2021;22:bbab271.","journal-title":"Brief Bioinform"},{"key":"1954_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5120\/20182-2402","volume":"115","author":"S Das","year":"2015","unstructured":"Das S, Dey A, Pal A, Roy N. Applications of Artificial Intelligence in Machine Learning: review and Prospect. IJCA. 2015;115:31\u201341.","journal-title":"IJCA"},{"key":"1954_CR56","doi-asserted-by":"crossref","unstructured":"Suryavanshi A, Kukreja V, Srivastava P, Bhattacherjee A, Rawat RS. Felis catus disease detection in the digital era: Combining CNN and Random Forest. 2023 International Conference on Artificial Intelligence for Innovations in Healthcare Industries (ICAIIHI) [Internet]. Raipur, India: IEEE; 2023 [cited 2024 May 10]. pp. 1\u20137. https:\/\/ieeexplore.ieee.org\/document\/10489457\/","DOI":"10.1109\/ICAIIHI57871.2023.10489457"},{"key":"1954_CR57","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1587\/transcom.2020EBP3180","volume":"E104B","author":"T Fujiwara","year":"2021","unstructured":"Fujiwara T, Denno S, Hou Y. Out-of-bound Signal Demapping for Lattice reduction-aided iterative Linear receivers in Overloaded MIMO systems. IEICE Trans Commun. 2021;E104B:974\u201382.","journal-title":"IEICE Trans Commun"},{"key":"1954_CR58","unstructured":"Gower RM, Schmidt M, Bach F, Richtarik P. Variance-Reduced Methods for Machine Learning [Internet]. arXiv; 2020 [cited 2024 May 10]. http:\/\/arxiv.org\/abs\/2010.00892"},{"key":"1954_CR59","doi-asserted-by":"publisher","first-page":"108341","DOI":"10.1016\/j.compbiomed.2024.108341","volume":"173","author":"Y Ying","year":"2024","unstructured":"Ying Y, Wang L, Ma S, Zhu Y, Ye S, Jiang N, et al. An enhanced machine learning approach for effective prediction of IgA nephropathy patients with severe proteinuria based on clinical data. Comput Biol Med. 2024;173:108341.","journal-title":"Comput Biol Med"},{"key":"1954_CR60","doi-asserted-by":"publisher","first-page":"11044","DOI":"10.1038\/s41598-023-38243-1","volume":"13","author":"A Godlewski","year":"2023","unstructured":"Godlewski A, Czajkowski M, Mojsak P, Pienkowski T, Gosk W, Lyson T, et al. A comparison of different machine-learning techniques for the selection of a panel of metabolites allowing early detection of brain tumors. Sci Rep. 2023;13:11044.","journal-title":"Sci Rep"},{"key":"1954_CR61","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1016\/j.molcel.2023.10.020","volume":"83","author":"R Foy","year":"2023","unstructured":"Foy R, Crozier L, Pareri AU, Valverde JM, Park BH, Ly T, et al. Oncogenic signals prime cancer cells for toxic cell overgrowth during a G1 cell cycle arrest. Mol Cell. 2023;83:4047\u2013e40616.","journal-title":"Mol Cell"},{"key":"1954_CR62","doi-asserted-by":"crossref","unstructured":"Liby KT, Sporn MB. Synthetic Oleanane Triterpenoids: Multifunctional Drugs with a Broad Range of Applications for Prevention and Treatment of Chronic Disease. Esbenshade TA, editor. Pharmacol Rev. 2012;64:972\u20131003.","DOI":"10.1124\/pr.111.004846"},{"key":"1954_CR63","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.ekir.2020.03.030","volume":"5","author":"M Nangaku","year":"2020","unstructured":"Nangaku M, Kanda H, Takama H, Ichikawa T, Hase H, Akizawa T. Randomized Clinical Trial on the Effect of Bardoxolone Methyl on GFR in Diabetic kidney disease patients (TSUBAKI Study). Kidney Int Rep. 2020;5:879\u201390.","journal-title":"Kidney Int Rep"},{"key":"1954_CR64","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41392-021-00628-x","volume":"6","author":"Q Sun","year":"2021","unstructured":"Sun Q, Ye F, Liang H, Liu H, Li C, Lu R, et al. Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3\u00a0C-like protease. Sig Transduct Target Ther. 2021;6:212.","journal-title":"Sig Transduct Target Ther"},{"key":"1954_CR65","doi-asserted-by":"publisher","first-page":"e13080","DOI":"10.1016\/j.heliyon.2023.e13080","volume":"9","author":"R Yang","year":"2023","unstructured":"Yang R, Guo Y, Zong S, Ma Z, Wang Z, Zhao J, et al. Bardoxolone methyl ameliorates osteoarthritis by inhibiting osteoclastogenesis and protecting the extracellular matrix against degradation. Heliyon. 2023;9:e13080.","journal-title":"Heliyon"},{"key":"1954_CR66","doi-asserted-by":"crossref","unstructured":"Onuma K, Watanabe K, Isayama K, Ogi S, Tokunaga Y, Mizukami Y. Bardoxolone methyl prevents metabolic dysfunction-associated steatohepatitis by inhibiting macrophage infiltration. British J Pharmacology. 2024;bph.16374.","DOI":"10.1111\/bph.16374"},{"key":"1954_CR67","doi-asserted-by":"crossref","unstructured":"Wang Y, Porter WW, Suh N, Honda T, Gribble GW, Leesnitzer LM et al. A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic Acid (CDDO), Is a ligand for the peroxisome proliferator-activated receptor \u03b3. Mol Endo. 14(10):1550\u201356.","DOI":"10.1210\/mend.14.10.0545"},{"key":"1954_CR68","doi-asserted-by":"publisher","first-page":"4949","DOI":"10.1158\/0008-5472.CAN-09-1962","volume":"70","author":"T Tsao","year":"2010","unstructured":"Tsao T, Kornblau S, Safe S, Watt JC, Ruvolo V, Chen W, et al. Role of peroxisome proliferator-activated Receptor-\u03b3 and its Coactivator DRIP205 in Cellular responses to CDDO (RTA-401) in Acute Myelogenous Leukemia. Cancer Res. 2010;70:4949\u201360.","journal-title":"Cancer Res"},{"key":"1954_CR69","unstructured":"Ikeda T, Sporn M, Honda T, Gribble GW, Kufe D. The Novel Triterpenoid CDDO and its derivatives induce Apoptosis by Disruption of Intracellular Redox Balance. Cancer Res 2003;63:5551\u201358."},{"key":"1954_CR70","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1158\/0008-5472.CAN-04-3319","volume":"65","author":"ML Hyer","year":"2005","unstructured":"Hyer ML, Croxton R, Krajewska M, Krajewski S, Kress CL, Lu M, et al. Synthetic triterpenoids cooperate with Tumor Necrosis factor\u2013related apoptosis-inducing ligand to Induce apoptosis of breast Cancer cells. Cancer Res. 2005;65:4799\u2013808.","journal-title":"Cancer Res"},{"key":"1954_CR71","doi-asserted-by":"publisher","first-page":"7484","DOI":"10.1158\/0008-5472.CAN-08-1318","volume":"68","author":"W Zou","year":"2008","unstructured":"Zou W, Yue P, Khuri FR, Sun S-Y. Coupling of endoplasmic reticulum stress to CDDO-Me\u2013Induced Up-regulation of death receptor 5 via a CHOP\u2013Dependent mechanism involving JNK activation. Cancer Res. 2008;68:7484\u201392.","journal-title":"Cancer Res"},{"key":"1954_CR72","unstructured":"Wang X-Y, Zhang X-H, Peng L, Liu Z, Yang Y-X, He Z-X et al. Bardoxolone methyl (CDDO-Me or RTA402) induces cell cycle arrest, apoptosis and autophagy via PI3K\/Akt\/mTOR and p38 MAPK\/Erk1\/2 signaling pathways in K562 cells. Am J Transl Res 2017;9(10):4652\u201372."},{"key":"1954_CR73","doi-asserted-by":"crossref","unstructured":"Ryu K, Susa M, Choy E, Yang C, Hornicek FJ, Mankin HJ et al. Oesleearachnaraticnlee triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway. BMC Cancer. 2010;10:187.","DOI":"10.1186\/1471-2407-10-187"},{"key":"1954_CR74","unstructured":"Deeb D, Gao X, Liu YB, Gautam SC. Inhibition of cell proliferation and induction of apoptosis by CDDO-Me in pancreatic cancer cells is ROS-dependent. J Exp Ther Oncol. 2012;10(1):51\u201364."},{"key":"1954_CR75","doi-asserted-by":"crossref","unstructured":"Bernstein SH, Venkatesh S, Li M, Lee J, Lu B, Hilchey SP et al. The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivatives.  Blood. 2012;119(14):3321\u201329.","DOI":"10.1182\/blood-2011-02-340075"},{"key":"1954_CR76","doi-asserted-by":"crossref","unstructured":"Qin D, Wang W, Lei H, Luo H, Cai H, Tang C et al. CDDO-Me reveals USP7 as a novel target in ovarian cancer cells. Oncotarget. 2016;7:77096\u2013109.","DOI":"10.18632\/oncotarget.12801"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01954-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-024-01954-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01954-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T10:54:32Z","timestamp":1733396072000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-024-01954-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1954"],"URL":"https:\/\/doi.org\/10.1186\/s12964-024-01954-7","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"2 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal use and experimental procedures were approved by the Institutional Animal Care and Use Committee of Shanghai Ocean University (Shanghai, China).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"585"}}